Cargando…
Targeting Chemoresistant Tumors: Could TRIM Proteins-p53 Axis Be a Possible Answer?
Chemosensitivity is a crucial feature for all tumours so that they can be successfully treated, but the huge heterogeneity of these diseases, to be intended both inter- and intra-tumour, makes it a hard-to-win battle. Indeed, this genotypic and phenotypic variety, together with the adaptability of t...
Autores principales: | Valletti, Alessio, Marzano, Flaviana, Pesole, Graziano, Sbisà, Elisabetta, Tullo, Apollonia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6479553/ https://www.ncbi.nlm.nih.gov/pubmed/30974870 http://dx.doi.org/10.3390/ijms20071776 |
Ejemplares similares
-
Emerging Roles of TRIM8 in Health and Disease
por: Marzano, Flaviana, et al.
Publicado: (2021) -
TRIM Proteins in Colorectal Cancer: TRIM8 as a Promising Therapeutic Target in Chemo Resistance
por: Marzano, Flaviana, et al.
Publicado: (2021) -
TRIM8 restores p53 tumour suppressor function by blunting N-MYC activity in chemo-resistant tumours
por: Mastropasqua, Francesca, et al.
Publicado: (2017) -
TRIM8 Blunts the Pro-proliferative Action of ΔNp63α in a p53 Wild-Type Background
por: Caratozzolo, Mariano Francesco, et al.
Publicado: (2019) -
The Underestimated Role of the p53 Pathway in Renal Cancer
por: Amendolare, Alessandra, et al.
Publicado: (2022)